| Literature DB >> 29355516 |
Tanyalak Parimon1, Rena Brauer1, Saundra Y Schlesinger2, Ting Xie1, Dianhua Jiang1, Lingyin Ge1, Ying Huang1, Timothy P Birkland2, William C Parks3, David M Habiel1, Cory M Hogaboam3, Sina A Gharib2, Nan Deng4, Zhenqui Liu5, Peter Chen6.
Abstract
Syndecan-1 is a transmembrane proteoglycan expressed prominently by lung epithelium and has pleiotropic functions such as regulating cell migration, proliferation, and survival. Loss of syndecan-1 expression by lung cancer cells is associated with higher-grade cancers and worse clinical prognosis. We evaluated the effects of syndecan-1 in various cell-based and animal models of lung cancer and found that lung tumorigenesis was moderated by syndecan-1. We also demonstrate that syndecan-1 (or lack thereof) alters the miRNA cargo carried within exosomes exported from lung cancer cells. Analysis of the changes in miRNA expression identified a distinct shift toward augmented procancer signaling consistent with the changes found in lung adenocarcinoma. Collectively, our work identifies syndecan-1 as an important factor in lung cancer cells that shapes the tumor microenvironment through alterations in miRNA packaging within exosomes.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29355516 PMCID: PMC5963476 DOI: 10.1016/j.ajpath.2017.12.009
Source DB: PubMed Journal: Am J Pathol ISSN: 0002-9440 Impact factor: 4.307